Prenatal Paternity Testing: CVS and Amniocentesis Options, Risks, and Timing
Establishing Paternity Before Birth
Two invasive prenatal tests can determine paternity with >99% accuracy. Both carry a small miscarriage risk (~0.1–0.3%) and are typically offered only when medically indicated or for compelling legal/personal reasons.
Chorionic Villus Sampling (CVS)
- Timing: 10–13 weeks gestation.
- Procedure: Transcervical or transabdominal catheter/needle samples placental chorionic villi.
- DNA Source: Fetal (placental) cells.
- Advantage: Earlier result.
- Risk: ~0.2–0.5% miscarriage; rare limb reduction defects if done <10 weeks.
Amniocentesis
- Timing: 15–20+ weeks.
- Procedure: Transabdominal needle withdraws 20–30 mL amniotic fluid.
- DNA Source: Fetal cells (amniocytes) in fluid.
- Advantage: Lower miscarriage risk (~0.1–0.3%); also diagnoses neural tube defects (AFP).
- Risk: Amniotic fluid leak, infection, Rh sensitization.
Non-Invasive Alternative
Cell-free fetal DNA (cffDNA) in maternal blood can determine paternity from ~9–10 weeks with no miscarriage risk. Not yet universally available for paternity; confirm lab accreditation.
Counseling Essential
Genetic counseling before testing to discuss risks, limitations, and implications.
Infertility - Related Articles
- How Smoking Impacts Male Fertility and Semen Quality
- Child Pregnancy: Biological Impossibility Before Puberty
- Necrotizing Enterocolitis (NEC) & Future Fertility: Current Evidence
- Conception Date Calculation: Pregnancy Timeline from Birth Date
- Understanding Postnatal Complications: Risks & Symptoms
- Can a Woman with Tubal Ligation Be a Surrogate? Fertility Facts & Surrogacy Requirements
- Where Does Fertilization Occur? Understanding Conception
